Nail damage caused by chemotherapy affects up to 90% of patients, not only causing physical harm, but significantly impacting their quality of life.
Due to a historical lack of reliable, evidence-based solutions, nail damage remains an under-diagnosed and under-treated issue in holistic cancer care.
Furthermore, emerging evidence shows that some targeted therapies and immunotherapies are causing nail toxicities just as frequently as long established chemotherapies and hormonal therapies.
Join us online on Tuesday 7th July at 8:00 AM (BST) for a fascinating and engaging session dealing with this common problem, featuring:
Professor Rob Thomas (Oncologist): Prof. Thomas will discuss his clinical experience with nail toxicities and the impact on patients, his frustration at the lack of proven treatment options that lead him to develop a reliable, evidence-based solution backed by clinical data.
A Patient Perspective (The Royal Marsden): A patient will share her personal journey with nail damage, her many failed attempts to address it, the emotional toll it took, and her highly positive experience using Polybalm.
This session promises to equip you with the knowledge to successfully address this problem that has, until now, been difficult to manage.
Book your space here: https://events.teams.microsoft.com/event/2c5634f6-2b70-43fa-9a34-04dee054653f@d8f58244-589f-4088-8060-f07afbe7d0b3
Looking for CPD hours? You can also take our fully funded, accredited CPD course on cancer therapy nail damage by clicking here: https://cpd.polybalm.com/courses/recognising-and-managing-nail-damage-during-cancer-therapy/
We look forward to seeing you on the Tuesday 7th of July at 8am. If you have any questions, please email care@Polybalm.com
